68Ga-FAPI-04 PET/MR Versus 18F-FDG PET/CT in the Detection of Ovarian Cancer
- 1 June 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (6) , 525-527
Abstract
A 75-year-old woman presented with right lower abdominal pain. Pelvic ultrasound showed a cystic solid mass in the right adnexa. Painless enlarged lymph nodes on the left supraclavicular side with biopsy were suggestive of metastatic cancer. 18F-FDG PET/CT performed to evaluate the primary tumor showed intense uptake in both regions of the right adnexa and the gastric sinus, but 68Ga-FAPI PET/MRI showed uptake only in the right adnexal region. A subsequent gastroscopic biopsy confirmed atrophic inflammation. Finally, surgery histopathology revealed ovarian cancer. This case demonstrated that 68Ga-FAPI PET/MRI may help exclude suspected primary gastric carcinoma with false-positive 18F-FDG uptake.Keywords
This publication has 8 references indexed in Scilit:
- Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung CancerRadiology, 2022
- Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- 68Ga-FAPI-PET/CT in patients with various gynecological malignanciesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver MetastasesClinical Nuclear Medicine, 2021
- Fibroblast Activation Protein Inhibitor PET/CTClinical Nuclear Medicine, 2020
- High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancerBMC Cancer, 2020
- Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- 18F-FDG PET/CT Imaging In OncologyAnnals of Saudi Medicine, 2011